EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Colistin resistance mechanisms in Gram-negative bacteria: a Focus on Escherichia coli

Mohammad Abavisani iD, Narjess Bostanghadiri, Hossein Ghahramanpour, Mansoor Kodori, Fariba Akrami, Hadis Fathizadeh, Ali Hashemi, Mohsen Rastegari-Pouyani

Letters in Applied Microbiology · 2023

DOI: 10.1093/lambio/ovad023 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Letters in Applied Microbiology, 2023. Verfasst von Mohammad Abavisani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Mashhad University of Medical Sciences, 9138813944 Mashhad, Iran. Hauptthemen laut MEDLINE: Escherichia coli Proteins, Escherichia coli Infections. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 135 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multidrug-resistant (MDR) Escherichia coli strains have rapidly increased worldwide, and effective antibiotic therapeutic options are becoming more restricted. As a polymyxin antibiotic, colistin has a long history of usage, and it is used as a final line of treatment for severe infections by Gram-negative bacteria (GNB) with high-level resistance. However, its application has been challenged by the emergence of E. coli colistin resistance. Hence, determining the mechanism that confers colistin resistance is crucial for monitoring and controlling the dissemination of colistin-resistant E. coli strains. This comprehensive review summarizes colistin resistance mechanisms in E. coli strains and concentrates on the history, mode of action, and therapeutic implications of colistin. We have mainly focused on the fundamental mechanisms of colistin resistance that are mediated by chromosomal or plasmid elements and discussed major mutations in the two-component systems (TCSs) genes and plasmids that transmit the mobilized colistin resistance resistant genes in E. coli strains.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Escherichia coli ProteinsEscherichia coli InfectionsHumansColistinEscherichia coliDrug Resistance, BacterialAnti-Bacterial AgentsPlasmidsMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Escherichia colimcr-genesGram-negative bacteriaantibiotics resistancecolistin

Substanzen

ColistinEscherichia coli ProteinsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Student Research Committee, Mashhad University of Medical Sciences, 9138813944 Mashhad, Iran.
  • Department of Microbiology, School of Medicine, Iran University of Medical Sciences, 1449614535 Tehran, Iran.
  • Department of Bacteriology, Faculty of medical sciences, Tarbiat Modares University, 1411713116 Tehran, Iran.
  • Noncommunicable Diseases Research Center, Bam University of Medical Sciences, 7661771967 Bam, Iran.
  • INRS-Centre Armand-Frappier Sante Biotechnologie, H7V 1B7Laval, Quebec, Canada.
  • Student Research Committee, Sirjan School of Medical Sciences, 7816916338 Sirjan, Iran.

ORCID-Profile: Mohammad Abavisani

Zitieren

APA

Abavisani, M., Bostanghadiri, N., Ghahramanpour, H., Kodori, M., Akrami, F., Fathizadeh, H., Hashemi, A., & Rastegari-Pouyani, M. (2023). Colistin resistance mechanisms in Gram-negative bacteria: a Focus on Escherichia coli. Letters in Applied Microbiology. https://doi.org/10.1093/lambio/ovad023

Vancouver

Abavisani M, Bostanghadiri N, Ghahramanpour H, Kodori M, Akrami F, Fathizadeh H, et al. Colistin resistance mechanisms in Gram-negative bacteria: a Focus on Escherichia coli. Letters in Applied Microbiology. 2023. doi:10.1093/lambio/ovad023

BibTeX
@article{Abavisani2023,
  author = {Abavisani, Mohammad and Bostanghadiri, Narjess and Ghahramanpour, Hossein and Kodori, Mansoor and Akrami, Fariba and Fathizadeh, Hadis and Hashemi, Ali and Rastegari-Pouyani, Mohsen},
  title = {Colistin resistance mechanisms in Gram-negative bacteria: a Focus on Escherichia coli},
  journal = {Letters in Applied Microbiology},
  year = {2023},
  doi = {10.1093/lambio/ovad023}
}
Kostenlos starten →